Lab tools & diagnostics
Instruments, supplies and testing services for labs, drugmakers and doctors.
Agrupadas con ayuda de un modelo de IA y revisadas por nuestros editores. La línea bajo cada empresa explica por qué está aquí.
Los precios de las acciones son el cierre del 11 nov 2026, del feed de la bolsa IEX.
Grade mix
A 8B 8C 2D 1F 1
Revenue growing
19 of 20
Free cash flow growing
9 of 20
Median price move, 1 year
+22,0 %
- TMOTHERMO FISHER SCIENTIFIC INC.
Diagnostics and researchMarket cap 265,9B US$P/E 37,85
717,62 US$+22,5 %1YSince added +8,2 %
A+- Crecimiento y caja
- Creciendo con fuerza
- Business trend
- Acelerando
- Business quality
- Fuerte
- Getting better
- Mejorando
Revenue
47,4B US$+8,3 %Profit
7,1B US$+7,6 %Free cash flow
7,6B US$+24,3 %Why it is here: Sells lab instruments, reagents and services to researchers and drug makers
- DHRDANAHER CORPORATION
Diagnostics and researchMarket cap 165,5B US$P/E 38,51
235,31 US$+8,0 %1YSince added +5,4 %
B+- Crecimiento y caja
- Creciendo con fuerza
- Business trend
- Acelerando
- Business quality
- Fuerte
- Getting better
- Mejorando
Revenue
25,6B US$+5,5 %Profit
4,3B US$+23,6 %Free cash flow
5,7B US$+14,2 %Why it is here: Sells research instruments, supplies and services
- AAGILENT TECHNOLOGIES, INC.
Diagnostics and researchMarket cap 49,9B US$P/E 34,89
176,91 US$+17,6 %1YSince added +3,1 %
B+- Crecimiento y caja
- Creciendo con fuerza
- Business trend
- Acelerando
- Business quality
- Fuerte
- Getting better
- Mejorando
Revenue
7,4B US$+8,6 %Profit
1,4B US$+18,0 %Free cash flow
1,3B US$+16,5 %Why it is here: Sells lab instruments, consumables and software to labs and drug makers
- WATWaters Corporation
Diagnostics and researchMarket cap 46,3B US$P/E 202,08
470,84 US$+21,5 %1YSince added +9,7 %
D- Crecimiento y caja
- Creciendo
- Business trend
- Desacelerando
- Business quality
- Mixta
- Getting better
- Mixto
Revenue
5,6B US$+84,2 %Profit
98,6M US$-84,8 %Free cash flow
290,8M US$-51,7 %Why it is here: Sells liquid chromatography and mass spectrometry instruments and consumables
- MTDMettler-Toledo International Inc.
Diagnostics and researchMarket cap 34,8B US$P/E 37,95
1749,30 US$+20,8 %1YSince added +9,4 %
B+- Crecimiento y caja
- Creciendo con fuerza
- Business trend
- Estable
- Business quality
- Fuerte
- Getting better
- Mejorando
Revenue
4,2B US$+6,5 %Profit
934,1M US$+11,8 %Free cash flow
870,6M US$-2,1 %Why it is here: Makes precision laboratory instruments and weighing equipment
- ILMNIllumina, Inc.
Diagnostics and researchMarket cap 32,2B US$P/E 36,64
212,86 US$+74,5 %1YSince added -21,5 %
A+- Crecimiento y caja
- Creciendo con fuerza
- Business trend
- Estable
- Business quality
- Fuerte
- Getting better
- Mejorando con fuerza
Revenue
4,5B US$+5,8 %Profit
895M US$+27,5 %Free cash flow
1,1B US$+5,7 %Why it is here: Sells DNA sequencing instruments and reagents
- IDXXIDEXX LABORATORIES INC /DE
Diagnostics and researchMarket cap 55,4B US$P/E 47,37
703,00 US$-1,5 %1YSince added +35,2 %
A+- Crecimiento y caja
- Creciendo con fuerza
- Business trend
- Estable
- Business quality
- Fuerte
- Getting better
- Mejorando con fuerza
Revenue
4,7B US$+11,9 %Profit
1,2B US$+15,1 %Free cash flow
1,3B US$+35,3 %Why it is here: Sells veterinary diagnostic tests and instruments
- DGXQuest Diagnostics Inc
Diagnostics and researchMarket cap 28,5B US$P/E 25,77
258,72 US$+40,8 %1YSince added +12,2 %
A- Crecimiento y caja
- Creciendo con fuerza
- Business trend
- Estable
- Business quality
- Sólida
- Getting better
- Mejorando
Revenue
11,8B US$+9,1 %Profit
1,1B US$+16,5 %Free cash flow
1,4B US$-1,3 %Why it is here: Provides diagnostic testing and clinical lab services
- LHLABCORP HOLDINGS INC.
Diagnostics and researchMarket cap 30,2B US$P/E 30,53
372,18 US$+41,3 %1YSince added +18,7 %
A- Crecimiento y caja
- Creciendo con fuerza
- Business trend
- Estable
- Business quality
- Mixta
- Getting better
- Mejorando con fuerza
Revenue
14,6B US$+6,0 %Profit
1B US$+17,4 %Free cash flow
1,3B US$-6,8 %Why it is here: Provides diagnostic tests and clinical lab services
- RVTYREVVITY, INC
Diagnostics and researchMarket cap 17,7B US$P/E 70,32
158,22 US$+68,5 %1YSince added +2,0 %
A- Crecimiento y caja
- Creciendo con fuerza
- Business trend
- Estable
- Business quality
- Mixta
- Getting better
- Mejorando
Revenue
2,9B US$+4,6 %Profit
253,2M US$+6,6 %Free cash flow
590,5M US$+18,7 %Why it is here: Sells lab instruments, reagents and diagnostics tools to research and drug makers
- IQVIQVIA HOLDINGS INC.
Diagnostics and researchMarket cap 45,2B US$P/E 33,38
274,37 US$+24,2 %1YSince added +5,2 %
A- Crecimiento y caja
- Creciendo con fuerza
- Business trend
- Estable
- Business quality
- Mixta
- Getting better
- Mejorando
Revenue
17,3B US$+8,8 %Profit
1,4B US$+8,7 %Free cash flow
2,1B US$-6,0 %Why it is here: Runs clinical trials and sells healthcare data to drugmakers
- NTRANATERA, INC.
Diagnostics and researchMarket cap 46,4B US$Sin PER (pérdida operativa)
319,77 US$+52,6 %1YSince added -19,2 %
B-- Crecimiento y caja
- Creciendo con fuerza
- Business trend
- Estable
- Business quality
- Débil
- Getting better
- Mixto
Revenue
2,9B US$+37,4 %Profit
-164,7M US$+46,7 %Free cash flow
52,5M US$-50,5 %Why it is here: Provides genetic and cell-free DNA diagnostic tests
- TECHBIO-TECHNE Corp
BiotechnologyMarket cap 11,4B US$P/E 66,77
72,78 US$+19,2 %1YSince added +0,4 %
A+- Crecimiento y caja
- Creciendo con fuerza
- Business trend
- Acelerando
- Business quality
- Fuerte
- Getting better
- Mejorando con fuerza
Revenue
1,2B US$+0,9 %Profit
172M US$+120,5 %Free cash flow
308,2M US$+37,6 %Why it is here: Sells proteins, antibodies and diagnostic reagents to researchers
- BRKRBRUKER CORPORATION
Medical devicesMarket cap 9,5B US$Sin PER (pérdida operativa)
62,41 US$+47,5 %1YSince added +11,0 %
B- Crecimiento y caja
- Creciendo con fuerza
- Business trend
- Desacelerando
- Business quality
- Mixta
- Getting better
- Mixto
Revenue
3,5B US$+2,2 %Profit
-123,4M US$-490,4 %Free cash flow
244,7M US$+2408,5 %Why it is here: Makes scientific instruments for microscopy, spectroscopy and magnetic resonance research
- RGENREPLIGEN CORP
Medical instruments and suppliesMarket cap 9,8B US$No P/E
172,68 US$+9,3 %1YSince added -1,6 %
B- Crecimiento y caja
- Creciendo con fuerza
- Business trend
- Desacelerando
- Business quality
- Mixta
- Getting better
- Mejorando
Revenue
805,6M US$+13,8 %Profit
-11,8M US$-779,2 %Free cash flow
106,7M US$-3,0 %Why it is here: Supplies bioprocessing filtration, chromatography and protein products to biologic drug makers
- BIOBIO-RAD LABORATORIES, INC.
Medical devicesMarket cap 10,4B US$Sin PER (pérdida operativa)
386,08 US$+18,0 %1YSince added +6,1 %
C- Crecimiento y caja
- Creciendo
- Business trend
- Estable
- Business quality
- Sólida
- Getting better
- Mejorando
Revenue
2,6B US$+1,4 %Profit
1B US$+251,3 %Free cash flow
329,1M US$-2,3 %Why it is here: Sells life science research tools and clinical diagnostics reagents and instruments
- QGENQIAGEN N.V.
Diagnostics and researchMarket cap 10,9B US$P/E 25,93
50,30 US$+19,8 %1YSince added +10,7 %
B+- Crecimiento y caja
- Creciendo con fuerza
- Business trend
- Estable
- Business quality
- Fuerte
- Getting better
- Mejorando
Revenue
2,1B US$+2,1 %Profit
384,5M US$-5,2 %Free cash flow
436,2M US$-8,9 %Why it is here: Supplies sample preparation and molecular testing kits and instruments
- GHGUARDANT HEALTH, INC.
Diagnostics and researchMarket cap 20,9B US$Sin PER (pérdida operativa)
154,76 US$+58,2 %1YSince added -4,5 %
B- Crecimiento y caja
- Creciendo con fuerza
- Business trend
- Estable
- Business quality
- Mixta
- Getting better
- Mixto
Revenue
1,3B US$+41,7 %Profit
-485,1M US$-21,6 %Free cash flow
-232,1M US$+11,5 %Why it is here: Provides blood-based cancer diagnostic tests
- MEDPMedpace Holdings, Inc.
Diagnostics and researchMarket cap 18,6B US$P/E 36,90
664,52 US$+11,2 %1YSince added +9,0 %
C+- Crecimiento y caja
- Creciendo con fuerza
- Business trend
- Desacelerando
- Business quality
- Fuerte
- Getting better
- Mejorando con fuerza
Revenue
2,8B US$+20,4 %Profit
517,8M US$+19,6 %Free cash flow
667,6M US$-1,4 %Why it is here: Runs clinical trials for biotech and pharma drug developers
- CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Diagnostics and researchMarket cap 16,4B US$P/E 353,20
342,61 US$+99,8 %1YSince added +14,5 %
F- Crecimiento y caja
- Mixto
- Business trend
- Contrayéndose
- Business quality
- Mixta
- Getting better
- Mixto
Revenue
4B US$-1,2 %Profit
40,2M US$+148,8 %Free cash flow
399,6M US$-26,5 %Why it is here: Provides preclinical research models and testing services to drug developers
Green and red compare each figure with the same window a year earlier. Grades and checks are the company page's own; nothing here is a recommendation.
Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.
DiscussionNo comments yet
Be civil and stick to the companies. Comments are opinions, not advice.